| Year |
Citation |
Score |
| 2021 |
Klausen MK, Thomsen M, Wortwein G, Fink-Jensen A. The role of glucagon-like peptide 1 (GLP-1) in addictive disorders. British Journal of Pharmacology. PMID 34532853 DOI: 10.1111/bph.15677 |
0.671 |
|
| 2021 |
Bornebusch AB, Mason GF, Tonetto S, Damsgaard J, Gjedde A, Fink-Jensen A, Thomsen M. Effects of ketogenic diet and ketone monoester supplement on acute alcohol withdrawal symptoms in male mice. Psychopharmacology. PMID 33410985 DOI: 10.1007/s00213-020-05735-1 |
0.628 |
|
| 2020 |
Jensen ME, Galli A, Thomsen M, Jensen KL, Thomsen GK, Klausen MK, Vilsbøll T, Christensen MB, Holst JJ, Owens A, Robertson S, Daws L, Zanella D, Gether U, Knudsen GM, ... Fink-Jensen A, et al. Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent. Neurochemistry International. 104772. PMID 32464226 DOI: 10.1016/J.Neuint.2020.104772 |
0.682 |
|
| 2020 |
Justinussen J, Dall C, Dencker D, Gjedde A, Fink-Jensen A, Thomsen M. Revealing a compulsive phenotype in cholinergic M mice depends on the inter-trial interval initiation settings in a five choice serial reaction time task. Behavioural Brain Research. 112649. PMID 32344038 DOI: 10.1016/J.Bbr.2020.112649 |
0.687 |
|
| 2019 |
Thomsen M, Holst JJ, Molander A, Linnet K, Ptito M, Fink-Jensen A. Correction to: Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys. Psychopharmacology. PMID 31768561 DOI: 10.1007/S00213-019-05374-1 |
0.648 |
|
| 2019 |
Bornebusch AB, Fink-Jensen A, Wörtwein G, Seeley RJ, Thomsen M. Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs. Eneuro. 6. PMID 31058214 DOI: 10.1523/ENEURO.0443-18.2019 |
0.661 |
|
| 2019 |
Brunchmann A, Thomsen M, Fink-Jensen A. The effect of glucagon-like PEPTIDE-1 (GLP-1) receptor agonists on substance use disorder (SUD)-related behavioural effects of drugs and alcohol: A systematic review. Physiology & Behavior. PMID 30946836 DOI: 10.1016/J.Physbeh.2019.03.029 |
0.722 |
|
| 2018 |
Thomsen M, Holst JJ, Molander A, Linnet K, Ptito M, Fink-Jensen A. Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys. Psychopharmacology. PMID 30382353 DOI: 10.1007/S00213-018-5089-Z |
0.676 |
|
| 2018 |
Antonsen KK, Klausen MK, Brunchmann AS, le Dous N, Jensen ME, Miskowiak KW, Fisher PM, Thomsen GK, Rindom H, Fahmy TP, Vollstaedt-Klein S, Benveniste H, Volkow ND, Becker U, Ekstrøm C, ... ... Fink-Jensen A, et al. Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial. Bmj Open. 8: e019562. PMID 30012779 DOI: 10.1136/Bmjopen-2017-019562 |
0.384 |
|
| 2018 |
Kucera R, Bouskila J, Elkrief L, Fink-Jensen A, Palmour R, Bouchard JF, Ptito M. Expression and localization of CB1R, NAPE-PLD, and FAAH in the vervet monkey nucleus accumbens. Scientific Reports. 8: 8689. PMID 29875385 DOI: 10.1038/S41598-018-26826-2 |
0.315 |
|
| 2017 |
Dencker D, Molander A, Thomsen M, Schlumberger C, Wortwein G, Weikop P, Benveniste H, Volkow ND, Fink-Jensen A. Ketogenic Diet suppresses Alcohol Withdrawal Syndrome in Rats. Alcoholism, Clinical and Experimental Research. PMID 29160944 DOI: 10.1111/Acer.13560 |
0.658 |
|
| 2017 |
Sørensen T, Jespersen HSR, Vinberg M, Becker U, Ekholm O, Fink-Jensen A. Substance use among Danish psychiatric patients: a cross-sectional study. Nordic Journal of Psychiatry. 1-7. PMID 29117747 DOI: 10.1080/08039488.2017.1400098 |
0.309 |
|
| 2017 |
Thomsen M, Dencker D, Wortwein G, Weikop P, Egecioglu E, Jerlhag E, Fink-Jensen A, Molander A. The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice. Pharmacology, Biochemistry, and Behavior. PMID 28778739 DOI: 10.1016/J.Pbb.2017.07.014 |
0.687 |
|
| 2017 |
Dall C, Weikop P, Dencker D, Molander AC, Wörtwein G, Conn PJ, Fink-Jensen A, Thomsen M. Muscarinic receptor M4 positive allosteric modulators attenuate central effects of cocaine. Drug and Alcohol Dependence. 176: 154-161. PMID 28544993 DOI: 10.1016/J.Drugalcdep.2017.03.014 |
0.701 |
|
| 2017 |
Jakobsen KD, Skyum E, Hashemi N, Schjerning O, Fink-Jensen A, Nielsen J. Antipsychotic treatment of schizotypy and schizotypal personality disorder: a systematic review. Journal of Psychopharmacology (Oxford, England). 31: 397-405. PMID 28347257 DOI: 10.1177/0269881117695879 |
0.302 |
|
| 2016 |
Reddy IA, Pino JA, Weikop P, Osses N, Sørensen G, Bering T, Valle C, Bluett RJ, Erreger K, Wortwein G, Reyes JG, Graham D, Stanwood GD, Hackett TA, Patel S, ... Fink-Jensen A, et al. Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels. Translational Psychiatry. 6: e809. PMID 27187231 DOI: 10.1038/Tp.2016.86 |
0.392 |
|
| 2016 |
Fink-Jensen A, Vilsbøll T. Glucagon-like peptide-1 (GLP-1) analogues: A potential new treatment for alcohol use disorder? Nordic Journal of Psychiatry. 70: 561-2. PMID 27151395 DOI: 10.1080/08039488.2016.1176252 |
0.335 |
|
| 2016 |
Askgaard G, Hallas J, Fink-Jensen A, Molander AC, Madsen KG, Pottegård A. Phenobarbital compared to benzodiazepines in alcohol withdrawal treatment: A register-based cohort study of subsequent benzodiazepine use, alcohol recidivism and mortality. Drug and Alcohol Dependence. PMID 26922279 DOI: 10.1016/J.Drugalcdep.2016.02.016 |
0.332 |
|
| 2015 |
Sørensen G, Reddy IA, Weikop P, Graham DL, Stanwood GD, Wortwein G, Galli A, Fink-Jensen A. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice. Physiology & Behavior. 149: 262-8. PMID 26072178 DOI: 10.1016/J.Physbeh.2015.06.013 |
0.457 |
|
| 2015 |
Andersen MB, Croy CH, Dencker D, Werge T, Bymaster FP, Felder CC, Fink-Jensen A. Antipsychotic-like effect of the muscarinic acetylcholine receptor agonist BuTAC in non-human primates. Plos One. 10: e0122722. PMID 25880220 DOI: 10.1371/Journal.Pone.0122722 |
0.474 |
|
| 2015 |
de la Cour C, Sørensen G, Wortwein G, Weikop P, Dencker D, Fink-Jensen A, Molander A. Enhanced self-administration of alcohol in muscarinic acetylcholine M4 receptor knockout mice. European Journal of Pharmacology. 746: 1-5. PMID 25445043 DOI: 10.1016/J.Ejphar.2014.10.050 |
0.43 |
|
| 2015 |
Dencker D, Wörtwein G, Lysne C, Weikop P, Fink-Jensen A, Molander A. P-49INACTIVATION OF THE CHOLINERGIC M4 RECEPTOR RESULTS IN THE DEVELOPMENT OF A LOW ANXIETY ENDOPHENOTYPE PREDICTING FUTURE ALCOHOL CONSUMPTION Alcohol and Alcoholism. 50: i57.4-i58. DOI: 10.1093/Alcalc/Agv080.49 |
0.418 |
|
| 2015 |
Dencker D, Egecioglu E, Jerlhag E, Wörtwein G, Weikop P, Fink-Jensen A, Molander A. SY15-2SUBCHRONIC LOW DOSE EXENDIN-4 PRETREATMENT INHIBITS RELAPSE TO ALCOHOL DRINKING IN HIGH ALCOHOL PREFERING C57BL6 MICE Alcohol and Alcoholism. 50: i17.4-i18. DOI: 10.1093/Alcalc/Agv076.62 |
0.359 |
|
| 2014 |
Larsen JR, Vedtofte L, Holst JJ, Oturai P, Kjær A, Correll CU, Corell CU, Vilsbøll T, Fink-Jensen A. Does a GLP-1 receptor agonist change glucose tolerance in patients treated with antipsychotic medications? Design of a randomised, double-blinded, placebo-controlled clinical trial. Bmj Open. 4: e004227. PMID 24667381 DOI: 10.1136/Bmjopen-2013-004227 |
0.361 |
|
| 2013 |
Sørensen G, Wörtwein G, Fink-Jensen A, Woldbye DP. Neuropeptide Y Y5 receptor antagonism causes faster extinction and attenuates reinstatement in cocaine-induced place preference. Pharmacology, Biochemistry, and Behavior. 105: 151-6. PMID 23454535 DOI: 10.1016/J.Pbb.2013.02.010 |
0.386 |
|
| 2012 |
Dencker D, Weikop P, Sørensen G, Woldbye DPD, Wörtwein G, Wess J, Fink-Jensen A. An allosteric enhancer of M4 muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocaine Psychopharmacology. 224: 277-287. PMID 22648127 DOI: 10.1007/S00213-012-2751-8 |
0.46 |
|
| 2012 |
Dencker D, Thomsen M, Wörtwein G, Weikop P, Cui Y, Jeon J, Wess J, Fink-Jensen A. Muscarinic Acetylcholine Receptor Subtypes as Potential Drug Targets for the Treatment of Schizophrenia, Drug Abuse and Parkinson's Disease. Acs Chemical Neuroscience. 3: 80-89. PMID 22389751 DOI: 10.1021/Cn200110Q |
0.718 |
|
| 2012 |
Sørensen G, Jensen M, Weikop P, Dencker D, Christiansen SH, Loland CJ, Bengtsen CH, Petersen JH, Fink-Jensen A, Wörtwein G, Woldbye DP. Neuropeptide Y Y5 receptor antagonism attenuates cocaine-induced effects in mice. Psychopharmacology. 222: 565-77. PMID 22367168 DOI: 10.1007/S00213-012-2651-Y |
0.424 |
|
| 2011 |
Dencker D, Wörtwein G, Weikop P, Jeon J, Thomsen M, Sager TN, Mørk A, Woldbye DPD, Wess J, Fink-Jensen A. Involvement of a subpopulation of neuronal M 4 muscarinic acetylcholine receptors in the antipsychotic-like effects of the M 1/M 4 preferring muscarinic receptor agonist xanomeline Journal of Neuroscience. 31: 5905-5908. PMID 21508215 DOI: 10.1523/Jneurosci.0370-11.2011 |
0.721 |
|
| 2011 |
Schmidt LS, Thomsen M, Weikop P, Dencker D, Wess J, Woldbye DPD, Wortwein G, Fink-Jensen A. Increased cocaine self-administration in M 4 muscarinic acetylcholine receptor knockout mice Psychopharmacology. 216: 367-378. PMID 21373792 DOI: 10.1007/S00213-011-2225-4 |
0.725 |
|
| 2011 |
Fink-Jensen A, Schmidt LS, Dencker D, Schülein C, Wess J, Wörtwein G, Woldbye DPD. Antipsychotic-induced catalepsy is attenuated in mice lacking the M 4 muscarinic acetylcholine receptor European Journal of Pharmacology. 656: 39-44. PMID 21269601 DOI: 10.1016/J.Ejphar.2011.01.018 |
0.425 |
|
| 2011 |
Fabricius K, Steiniger-Brach B, Helboe L, Fink-Jensen A, Wörtwein G. Socially isolated rats exhibit changes in dopamine homeostasis pertinent to schizophrenia. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 29: 347-50. PMID 20884342 DOI: 10.1016/J.Ijdevneu.2010.09.003 |
0.327 |
|
| 2010 |
Fabricius K, Helboe L, Fink-Jensen A, Wörtwein G, Steiniger-Brach B, Sotty F. Increased dopaminergic activity in socially isolated rats: an electrophysiological study. Neuroscience Letters. 482: 117-22. PMID 20637831 DOI: 10.1016/J.Neulet.2010.07.014 |
0.315 |
|
| 2010 |
Jeon J, Dencker D, Wörtwein G, Woldbye DP, Cui Y, Davis AA, Levey AI, Schütz G, Sager TN, Mørk A, Li C, Deng CX, Fink-Jensen A, Wess J. A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 2396-405. PMID 20147565 DOI: 10.1523/Jneurosci.3843-09.2010 |
0.452 |
|
| 2010 |
Thomsen M, Wess J, Fulton BS, Fink-Jensen A, Caine SB. Modulation of prepulse inhibition through both M1 and M 4 muscarinic receptors in mice Psychopharmacology. 208: 401-416. PMID 20013114 DOI: 10.1007/S00213-009-1740-Z |
0.691 |
|
| 2010 |
Thomsen M, Conn PJ, Lindsley C, Wess J, Boon JY, Fulton BS, Fink-Jensen A, Caine SB. Attenuation of cocaine's reinforcing and discriminative stimulus effects via muscarinic M1 acetylcholine receptor stimulation Journal of Pharmacology and Experimental Therapeutics. 332: 959-969. PMID 19996296 DOI: 10.1124/Jpet.109.162057 |
0.717 |
|
| 2010 |
Schmidt LS, Miller AD, Lester DB, Bay-Richter C, Schülein C, Frikke-Schmidt H, Wess J, Blaha CD, Woldbye DP, Fink-Jensen A, Wortwein G. Increased amphetamine-induced locomotor activity, sensitization, and accumbal dopamine release in M5 muscarinic receptor knockout mice. Psychopharmacology. 207: 547-58. PMID 19820917 DOI: 10.1007/S00213-009-1685-2 |
0.475 |
|
| 2009 |
Sørensen G, Wegener G, Hasselstrøm J, Hansen TV, Wörtwein G, Fink-Jensen A, Woldbye DP. Neuropeptide Y infusion into the shell region of the rat nucleus accumbens increases extracellular levels of dopamine. Neuroreport. 20: 1023-6. PMID 19579268 DOI: 10.1097/Wnr.0B013E32832D4848 |
0.383 |
|
| 2008 |
Hansen T, Jakobsen KD, Fenger M, Nielsen J, Krane K, Fink-Jensen A, Lublin H, Ullum H, Timm S, Wang AG, Jørgensen NR, Werge T. Variation in the purinergic P2RX(7) receptor gene and schizophrenia. Schizophrenia Research. 104: 146-52. PMID 18614336 DOI: 10.1016/J.Schres.2008.05.026 |
0.311 |
|
| 2008 |
Thomsen M, Fink-Jensen A, Woldbye DP, Wörtwein G, Sager TN, Holm R, Pepe LM, Caine SB. Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats. Psychopharmacology. 201: 43-53. PMID 18612628 DOI: 10.1007/S00213-008-1245-1 |
0.688 |
|
| 2008 |
Sørensen G, Sager TN, Petersen JH, Brennum LT, Thøgersen P, Hee Bengtsen C, Thomsen M, Wörtwein G, Fink-Jensen A, Woldbye DP. Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice. Psychopharmacology. 199: 37-46. PMID 18481046 DOI: 10.1007/S00213-008-1069-Z |
0.722 |
|
| 2007 |
Andersen MB, Werge T, Fink-Jensen A. The acetylcholinesterase inhibitor galantamine inhibits d-amphetamine-induced psychotic-like behavior in Cebus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 321: 1179-82. PMID 17374745 DOI: 10.1124/Jpet.107.119677 |
0.375 |
|
| 2007 |
Thomsen M, Wörtwein G, Fink-Jensen A, Woldbye DP, Wess J, Caine SB. Decreased prepulse inhibition and increased sensitivity to muscarinic, but not dopaminergic drugs in M5 muscarinic acetylcholine receptor knockout mice. Psychopharmacology. 192: 97-110. PMID 17310388 DOI: 10.1007/S00213-006-0682-Y |
0.719 |
|
| 2005 |
Thomsen M, Woldbye DP, Wörtwein G, Fink-Jensen A, Wess J, Caine SB. Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 8141-9. PMID 16148222 DOI: 10.1523/Jneurosci.2077-05.2005 |
0.706 |
|
| 2003 |
Fink-Jensen A, Fedorova I, Wörtwein G, Woldbye DP, Rasmussen T, Thomsen M, Bolwig TG, Knitowski KM, McKinzie DL, Yamada M, Wess J, Basile A. Role for M5 muscarinic acetylcholine receptors in cocaine addiction. Journal of Neuroscience Research. 74: 91-6. PMID 13130510 DOI: 10.1002/Jnr.10728 |
0.717 |
|
| 2003 |
Andersen MB, Fink-Jensen A, Peacock L, Gerlach J, Bymaster F, Lundbaek JA, Werge T. The muscarinic M1/M4 receptor agonist xanomeline exhibits antipsychotic-like activity in Cebus apella monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1168-75. PMID 12700711 DOI: 10.1038/Sj.Npp.1300151 |
0.439 |
|
| 2003 |
Fink-Jensen A, Andersen M, Peacock L, Bymaster F, Gerlach J, Lundb˦k J, Werge T. The muscarinic agonists xanomeline and butac inhibit amphetamine-induced behavior in monkeys Schizophrenia Research. 60: 311. DOI: 10.1016/S0920-9964(03)80250-5 |
0.317 |
|
| 2001 |
Rasmussen T, Fink-Jensen A, Sauerberg P, Swedberg MD, Thomsen C, Sheardown MJ, Jeppesen L, Calligaro DO, DeLapp NW, Whitesitt C, Ward JS, Shannon HE, Bymaster FP. The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance. Schizophrenia Research. 49: 193-201. PMID 11343877 DOI: 10.1016/S0920-9964(00)00129-8 |
0.423 |
|
| 2000 |
Rasmussen T, Sauerberg P, Nielsen EB, Swedberg MD, Thomsen C, Sheardown MJ, Jeppesen L, Calligaro DO, DeLapp NW, Whitesitt C, Ward JS, Shannon HE, Bymaster FP, Fink-Jensen A. Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive mice. European Journal of Pharmacology. 402: 241-6. PMID 10958890 DOI: 10.1016/S0014-2999(00)00442-8 |
0.482 |
|
| 2000 |
Shannon HE, Rasmussen K, Bymaster FP, Hart JC, Peters SC, Swedberg MD, Jeppesen L, Sheardown MJ, Sauerberg P, Fink-Jensen A. Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice. Schizophrenia Research. 42: 249-59. PMID 10785583 DOI: 10.1016/S0920-9964(99)00138-3 |
0.455 |
|
| 2000 |
Fink-Jensen A, Rasmussen T, Shannon H, Calligaro D, Delapp N, Rasmussen K, Ward J, Sheardown M, Jeppesen L, Sauerberg P, Bymaster F. The selective muscarinic receptor agonist PTAC exhibits functional dopamine antagonism and decreases scopolamine-induced hyperactivity in rodents. Role of tegmental cholinergic neurons Schizophrenia Research. 41: 240. DOI: 10.1016/S0920-9964(00)90903-4 |
0.391 |
|
| 1999 |
Bymaster FP, Shannon HE, Rasmussen K, DeLapp NW, Ward JS, Calligaro DO, Mitch CH, Whitesitt C, Ludvigsen TS, Sheardown M, Swedberg M, Rasmussen T, Olesen PH, Jeppesen L, Sauerberg P, ... Fink-Jensen A, et al. Potential role of muscarinic receptors in schizophrenia. Life Sciences. 64: 527-34. PMID 10069519 DOI: 10.1016/S0024-3205(98)00597-9 |
0.447 |
|
| 1999 |
Shannon HE, Bymaster FP, Rasmussen K, DeLapp NW, Calligaro DO, Perry KW, Mitch CH, Ward JS, Fink-Jensen A, Olesen P, Rasmussen T, Sheardown M, Swedberg M, Jeppesen L, Sauerberg P. Behavioral and electrophysiological effects of the antipsychotic-like muscarinic agonist PTAC Life Sciences. 64: 587. DOI: 10.1016/S0024-3205(99)90529-5 |
0.339 |
|
| 1999 |
Bymaster FP, Shannon HE, DeLapp NW, Calligaro DO, Perry KW, Zhang W, Rasmussen K, Ward JS, Fink-Jensen A, Olesen P, Rasmussen T, Sheardown M, Swedberg M, Jeppesen L, Sauerberg P. Muscarinic receptor characterization and neurochemical effects of the antipsychotic-like muscarinic agonist PTAC Life Sciences. 64: 579. DOI: 10.1016/S0024-3205(99)90514-3 |
0.42 |
|
| 1999 |
Sauerberg P, Jeppesen L, Olesen PH, Rasmussen T, Swedberg MDB, Sheardown MJ, Fink-Jensen A, Thomsen C, Thøgersen H, Ward JS, Calligaro DO, DeLapp NW, Bymaster FP, Shannon HE. Muscarinic agonists with antipsychotic-like activity. Structure activity-relationships of 1,2,5-thiadiazole analogues with functioally dopamine antagonist activity Life Sciences. 64: 555. DOI: 10.1016/S0024-3205(98)00601-8 |
0.372 |
|
| 1998 |
Sauerberg P, Jeppesen L, Olesen PH, Sheardown MJ, Fink-Jensen A, Rasmussen T, Rimvall K, Shannon HE, Bymaster FP, DeLapp NW, Calligaro DO, Ward JS, Whitesitt CA, Thomsen C. Identification of side chains on 1,2,5-thiadiazole-azacycles optimal for muscarinic m1 receptor activation. Bioorganic & Medicinal Chemistry Letters. 8: 2897-902. PMID 9873644 DOI: 10.1016/S0960-894X(98)00509-5 |
0.352 |
|
| 1998 |
Fink-Jensen A, Kristensen P, Shannon HE, Calligaro DO, Delapp NW, Whitesitt C, Ward JS, Thomsen C, Rasmusseen T, Sheardown MJ, Jeppesen L, Sauerberg P, Bymaster FP. Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned rats. Neuroreport. 9: 3481-6. PMID 9855303 DOI: 10.1097/00001756-199810260-00027 |
0.406 |
|
| 1998 |
Sauerberg P, Jeppesen L, Olesen PH, Rasmussen T, Swedberg MD, Sheardown MJ, Fink-Jensen A, Thomsen C, Thøgersen H, Rimvall K, Ward JS, Calligaro DO, DeLapp NW, Bymaster FP, Shannon HE. Muscarinic agonists with antipsychotic-like activity: structure-activity relationships of 1,2,5-thiadiazole analogues with functional dopamine antagonist activity. Journal of Medicinal Chemistry. 41: 4378-84. PMID 9784113 DOI: 10.1021/Jm981048E |
0.373 |
|
| 1998 |
Bymaster FP, Shannon HE, Rasmussen K, Delapp NW, Mitch CH, Ward JS, Calligaro DO, Ludvigsen TS, Sheardown MJ, Olesen PH, Swedberg MD, Sauerberg P, Fink-Jensen A. Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane . European Journal of Pharmacology. 356: 109-19. PMID 9774240 DOI: 10.1016/S0014-2999(98)00487-7 |
0.462 |
|
| 1998 |
Bymaster FP, Carter PA, Peters SC, Zhang W, Ward JS, Mitch CH, Calligaro DO, Whitesitt CA, DeLapp N, Shannon HE, Rimvall K, Jeppesen L, Sheardown MJ, Fink-Jensen A, Sauerberg P. Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects. Brain Research. 795: 179-90. PMID 9622623 DOI: 10.1016/S0006-8993(98)00267-4 |
0.396 |
|
| 1998 |
Fink-Jensen A, Nielsen EB, Hansen L, Scheideler MA. Behavioral and neurochemical effects of the preferential dopamine D3 receptor agonist cis-8-OH-PBZI European Journal of Pharmacology. 342: 153-161. PMID 9548380 DOI: 10.1016/S0014-2999(97)01494-5 |
0.41 |
|
| 1998 |
DeLapp N, Wu S, Belagaje R, Johnstone E, Little S, Shannon H, Bymaster F, Calligaro D, Mitch C, Whitesitt C, Ward J, Sheardown M, Fink-Jensen A, Jeppesen L, Thomsen C, et al. Effects of the M1 agonist xanomeline on processing of human beta-amyloid precursor protein (FAD, Swedish mutant) transfected into Chinese hamster ovary-m1 cells. Biochemical and Biophysical Research Communications. 244: 156-160. PMID 9514902 DOI: 10.1006/Bbrc.1998.8235 |
0.324 |
|
| 1998 |
Hansen JB, Fink-Jensen A, Christensen BV, Grønvald FC, Jeppesen L, Mogensen JP, Nielsen EB, Scheideler MA, White FJ, Zhang XF. Mesolimbic selective antipsychotic arylcarbamates European Journal of Medicinal Chemistry. 33: 839-858. DOI: 10.1016/S0223-5234(99)80009-9 |
0.307 |
|
| 1997 |
Scheideler MA, Martin J, Hohlweg R, Rasmussen JS, Nærum L, Ludvigsen TS, Larsen PJ, Korsgaard N, Crider AM, Ghosh D, Cruse SF, Fink-Jensen A. The preferential dopamine D3 receptor agonist cis-8-OH-PBZI induces limbic Fos expression in rat brain European Journal of Pharmacology. 339: 261-270. PMID 9473144 DOI: 10.1016/S0014-2999(97)01372-1 |
0.387 |
|
| 1997 |
Shannon HE, Womer DE, Bymaster FP, Calligaro DO, DeLapp NC, Mitch CH, Ward JS, Whitesitt CA, Swedberg MD, Sheardown MJ, Fink-Jensen A, Olesen PH, Rimvall K, Sauerberg P. In vivo pharmacology of butylthio[2.2.2] (LY297802 / NNC11-1053), an orally acting antinociceptive muscarinic agonist. Life Sciences. 60: 969-76. PMID 9121363 DOI: 10.1016/S0024-3205(97)00036-2 |
0.42 |
|
| 1997 |
Hansen JB, Fink-Jensen A, Hansen L, Nielsen E, Scheideler M. Alkoxyfurocoumarin derivatives as potential mesolimbic selective antipsychotics European Journal of Medicinal Chemistry. 32: 103-111. DOI: 10.1016/S0223-5234(97)87536-8 |
0.308 |
|
| 1996 |
Tang-Christensen M, Larsen PJ, Goke R, Fink-Jensen A, Jessop DS, Moller M, Sheikh SP. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats American Journal of Physiology-Regulatory Integrative and Comparative Physiology. 271. PMID 8897973 DOI: 10.1152/Ajpregu.1996.271.4.R848 |
0.304 |
|
| 1996 |
Fink-Jensen A, Hansen L, Hansen JB, Nielsen EB. Regional differences in the effect of haloperidol and atypical neuroleptics on interstitial levels of DOPAC in the rat forebrain: An in vivo microdialysis study Journal of Psychopharmacology. 10: 119-125. DOI: 10.1177/026988119601000206 |
0.313 |
|
| 1995 |
Fink-Jensen A, Ludvigsen TS, Korsgaard N. The effect of clozapine on Fos protein immunoreactivity in the rat forebrain is not mimicked by the addition of alpha 1-adrenergic or 5HT2 receptor blockade to haloperidol. Neuroscience Letters. 194: 77-80. PMID 7478218 DOI: 10.1016/0304-3940(95)11731-B |
0.31 |
|
| 1994 |
Fink-Jensen A, Ingwersen SH, Nielsen PG, Hansen L, Nielsen EB, Hansen AJ. Halothane anesthesia enhances the effect of dopamine uptake inhibition on interstitial levels of striatal dopamine Naunyn-Schmiedeberg's Archives of Pharmacology. 350: 239-244. PMID 7824039 DOI: 10.1007/Bf00175028 |
0.321 |
|
| 1992 |
Fink-Jensen A, Judge ME, Hansen JB, Jacobsen P, Turski L, Olney J, Honoré T. Inhibition of cisplatin-induced emesis in ferrets by the non-NMDA receptor antagonists NBQX and CNQX. Neuroscience Letters. 137: 173-7. PMID 1350077 DOI: 10.1016/0304-3940(92)90397-P |
0.308 |
|
| Show low-probability matches. |